INTERNATIONAL PATENT: NURIX THERAPEUTICS, INC. FILES APPLICATION FOR "KLHDC COMPOUNDS FOR TARGETED PROTEIN DEGRADATION"

GENEVA, Feb. 18 -- NURIX THERAPEUTICS, INC. (1700 Owens Street, Suite 2054th FloorSan Francisco, CA 94158) filed a patent application (PCT/US2025/041136) for "KLHDC COMPOUNDS FOR TARGETED PROTEIN DEGRADATION" on Aug 07, 2025. With publication no. WO/2026/035963, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LANDSTROM, Evan, B. (c/o Nurix Therapeutics, Inc.1700 Owens Street, Suite 205San Francisco, CA 94158), MALONE, Marie, L. (c/o Nurix Therapeutics, Inc.1700 Owens Street, Suite 205San Francisco, CA 94158), PEMBERTON, R...